Position in FTRE
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$452
+$208 QoQ
Shares Held
26
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#300
of 331 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in FTRE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MTM Investment Management, LLC holds $95,077 across 10 Biotechnology names. FTRE ranks #8 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
117 | $58,117 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
258 | $20,456 | |
| 3 | IBRX |
ImmunityBio, Inc.
|
1,000 | $8,755 | |
| 4 | NKTR |
Nektar Therapeutics
|
66 | $4,607 | |
| 5 | HUMA |
Humacyte, Inc.
|
1,100 | $858 | |
| 6 | CRSP |
CRISPR Therapeutics AG
|
15 | $818 | |
| 7 | MDXG |
Mimedx Group, Inc.
|
163 | $627 | |
| 8 | FTRE |
Fortrea Holdings Inc.
This page
|
26 | $452 |
All Filings in FTRE
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $452 | 26 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $244 | 26 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $448 | 26 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $218 | 26 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $128 | 26 | Shares | Sole | 2025-08-08 | |
| No filing history on record for this holder in this stock. | ||||||